Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer COMMENT

被引：0
|
作者：
Singer, Frederick R. [1 ]
机构：
[1] St Johns Hlth Ctr, John Wayne Canc Inst, Endocrine Bone Dis Program, Santa Monica, CA USA
来源：
JOURNAL OF UROLOGY | 2009年 / 182卷 / 06期
关键词：
D O I：
10.1016/j.juro.2009.08.193
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2676 / 2676
页数：1
相关论文
共 50 条
  • [21] Bone health in men receiving androgen deprivation therapy for prostate cancer
    Eastham, James A.
    [J]. JOURNAL OF UROLOGY, 2007, 177 (01): : 17 - 24
  • [22] Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy
    Neubecker, Katherine
    Adams-Huet, Beverley
    Farukhi, Irfan M.
    Delapena, Rosinda C.
    Gruntmanis, Ugis
    [J]. JOURNAL OF OSTEOPOROSIS, 2011, 2011
  • [23] Rates of bone mineral density measurement in men with prostate cancer starting androgen deprivation therapy
    Suarez-Almazor, Maria
    Peddi, Prashanth
    Luo, Ruili
    Hoang Nguyen
    Elting, Linda S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [24] Denosumab for prevention of fractures in men receiving androgen deprivation therapy (ADT) for prostate cancer (PC)
    Saad, F.
    Smith, M. R.
    Egerdie, B.
    Tammela, T. L.
    Feldman, R. A.
    Heracek, J.
    Szwedowski, M.
    Ke, C.
    Leder, B.
    Goessl, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] Contemporary analysis of bone mineral density in men initiating androgen deprivation therapy for prostate cancer.
    Hu, Jason
    Aprikian, Armen G.
    Vanhuyse, Marie
    Dragomir, Alice
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27)
  • [26] Bone mineral density, structure, distribution and strength in men with prostate cancer treated with androgen deprivation therapy
    Dalla Via, Jack
    Daly, Robin M.
    Owen, Patrick J.
    Mundell, Niamh L.
    Rantalainen, Timo
    Fraser, Steve F.
    [J]. BONE, 2019, 127 : 367 - 375
  • [27] Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer
    Panju, Abbas H.
    Breunis, Henriette
    Cheung, Angela M.
    Leach, Marc
    Fleshner, Neil
    Warde, Padraig
    Duff-Canning, Sarah
    Krahn, Murray
    Naglie, Gary
    Tannock, Ian
    Tomlinson, George
    Alibhai, Shabbir M. H.
    [J]. BJU INTERNATIONAL, 2009, 103 (06) : 753 - 757
  • [28] Phase III interim analysis demonstrates toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer
    Smith, Matthew R.
    Chu, F.
    Forrest, J.
    Malkowicz, S. Bruce
    Price, David
    Sieber, P.
    Barnette, K. G.
    Rodriguez, D.
    Steiner, M. S.
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 335 - 335
  • [29] Risk Factors for Bone Loss with Prostate Cancer in Korean Men Not Receiving Androgen Deprivation Therapy EDITORIAL COMMENT
    Brufsky, A. M.
    [J]. INTERNATIONAL BRAZ J UROL, 2009, 35 (02): : 189 - 189
  • [30] Effect of androgen deprivation therapy on bone mineral density in prostate cancer patients
    Deng, JH
    Yang, LP
    Wang, LS
    Zhou, DF
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2004, 6 (01) : 75 - 77
12345